We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NT-proBNP

News List

Biomarker May Predict Cardiac Risk in Noncardiac Surgery drugs
December 24, 2019
The preoperative level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) is associated with vascular death and myocardial injury after noncardiac surgery (MINS) ...
"Biomarkers can play a key role in improving diagnosis and disease management of heart failure. " biospectrumasia
November 15, 2018
Recently, Priyanka Bajpai from BioSpectrum Asia spoke to Dr Antoni Bayes-Genis on the need to staying healthy and the future of NT-proBNP as a cardiac biomarker.
Novartis' Entresto tops enalapril in stabilised heart failure patients pharmatimes
November 14, 2018
Novartis has declared new findings for Entresto (sacubitril/valsartan) at the American Heart Association's (AHA) scientific sessions, showing that the drug proved